InteliCare Holdings Limited (AU:ICR)
ASX:ICR
Top Page
InteliCare Holdings Limited
(Sydney:ICR)
Select Model
Select Model
Rating:42Neutral
Price Target:
AU$0.02
▼(-5.00% Downside)
Action:ReiteratedDate:03/28/26
The score is weighed down primarily by weak financial performance—negative gross profit, persistent losses, ongoing cash burn, and negative equity. Technical indicators are mixed and do not show strong bullish momentum, while valuation is constrained by loss-making results and lack of dividend support.
Positive Factors
Revenue Growth
A ~45% revenue rebound to A$0.96m indicates improving market traction and product adoption. Sustained top-line growth demonstrates demand for the platform and gives management runway to leverage fixed costs, improving the odds of reaching scale-driven profitability over the medium term.
Negative Factors
Negative Equity
Negative equity reflects cumulative losses that have eroded the capital base, limiting financial flexibility. This structural weakness raises refinancing risk, can constrain borrowing, and increases reliance on external capital or dilutive raises to fund operations over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
A ~45% revenue rebound to A$0.96m indicates improving market traction and product adoption. Sustained top-line growth demonstrates demand for the platform and gives management runway to leverage fixed costs, improving the odds of reaching scale-driven profitability over the medium term.
Read all positive factors
InteliCare Holdings Limited (ICR) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$14.30M
Dividend YieldN/A
Average Volume (3M)1.91M
Price to Earnings (P/E)―
Beta (1Y)-0.12
Revenue Growth241.34%
EPS Growth44.19%
CountryAU
EmployeesN/A
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding621,890,140
10 Day Avg. Volume3,223,113
30 Day Avg. Volume1,908,177
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)-3.27
Price to Sales (P/S)2.85
P/FCF Ratio-1.63
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
InteliCare Holdings Limited Business Overview & Revenue Model
Company Description
Intelicare Holdings Limited engages in the sale of a predictive analytics hardware and software package for use in the aged care and health industries in Australia. The company offers InteliLiving for seniors and people with disability; and produc...
How the Company Makes Money
InteliCare Holdings Limited generates revenue through the sale of its monitoring systems and subscription-based services. Customers, including individual consumers, aged care providers, and healthcare facilities, purchase the IoT hardware and pay ...
InteliCare Holdings Limited Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
27
Negative
Cash Flow
21
Negative
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 945.45K | 956.74K | 280.29K | 404.35K | 429.85K | 363.12K |
| Gross Profit | -1.24M | -1.09M | -1.79M | -2.69M | -2.75M | -1.99M |
| EBITDA | -2.70M | -2.16M | -3.02M | -2.89M | -3.78M | -4.24M |
| Net Income | -2.84M | -2.24M | -2.26M | -3.00M | -3.93M | -4.36M |
Balance Sheet | ||||||
| Total Assets | 1.64M | 1.02M | 1.52M | 2.48M | 2.88M | 3.43M |
| Cash, Cash Equivalents and Short-Term Investments | 1.05M | 410.53K | 834.20K | 1.94M | 2.27M | 2.67M |
| Total Debt | 1.09M | 716.62K | 612.39K | 726.57K | 18.25K | 85.16K |
| Total Liabilities | 1.86M | 1.86M | 1.69M | 1.53M | 1.34M | 842.64K |
| Stockholders Equity | -222.63K | -833.17K | -168.32K | 949.11K | 1.54M | 2.59M |
Cash Flow | ||||||
| Free Cash Flow | -2.56M | -1.67M | -1.66M | -3.11M | -3.14M | -3.86M |
| Operating Cash Flow | -2.55M | -1.67M | -1.66M | -3.10M | -3.10M | -3.79M |
| Investing Cash Flow | -6.45K | -7.09K | 0.00 | -14.35K | -32.92K | -74.79K |
| Financing Cash Flow | 2.35M | 1.25M | 555.65K | 2.78M | 2.73M | 2.34M |
InteliCare Holdings Limited Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
43 Neutral | AU$2.06M | -1.11 | -42.29% | ― | ― | 78.95% | |
43 Neutral | AU$69.45M | -6.64 | -59.96% | ― | ― | ― | |
43 Neutral | AU$40.33M | -4.21 | -52.26% | ― | -36.68% | 79.41% | |
42 Neutral | AU$14.30M | -2.48 | -578.72% | ― | 241.34% | 44.19% | |
41 Neutral | AU$3.94M | -1.98 | 20.02% | ― | -9.90% | 34.07% | |
41 Neutral | AU$8.86M | -0.96 | 152.58% | ― | -40.05% | -49.57% |
* Healthcare Sector Average
AU:ICR
InteliCare Holdings Limited
0.02
0.01
130.00%
AU:TD1
Tali Digital
0.04
-0.03
-37.14%
AU:GLH
Global Health Limited
0.07
-0.05
-41.74%
AU:SHG
Singular Health Group Ltd
0.22
-0.01
-6.38%
AU:EMD
Emyria Ltd
0.05
0.02
66.67%
AU:HIQ
HitIQ Limited
0.01
-0.02
-60.00%
InteliCare Holdings Limited Corporate Events
InteliCare Confirms Compliance in Performance Rights Disclosure
Mar 27, 2026
InteliCare Holdings has issued a notice under section 708A(5) of the Corporations Act confirming the recent issue of performance rights by the company. The board states that the company is fully compliant with its financial reporting and continuou...
InteliCare Plans Issue of 16.5 Million Performance Rights on ASX
Mar 27, 2026
InteliCare Holdings Limited has lodged details with the ASX for a proposed issue of up to 16,500,000 performance rights under the security code ICRAP. The issue is structured as a placement or other type of security issue, with the proposed issue ...
InteliCare to Highlight AI Care Platform at NWR Virtual Healthcare Conference
Mar 25, 2026
InteliCare Holdings Ltd, an Australian SaaS technology company specialising in AI-driven predictive analytics and IoT-based hardware and software for aged care, disability and health, delivers both B2B and B2C solutions. Its platform uses smart se...
InteliCare appoints veteran health-tech executive Angus Cameron as CEO to drive scale-up
Mar 16, 2026
InteliCare Holdings has appointed veteran global aged and health care executive Angus Cameron as chief executive officer, effective immediately. Cameron brings more than three decades of international experience across Australia, Asia Pacific and ...
InteliCare secures $8.8m mecwacare deal in largest aged care rollout
Mar 11, 2026
InteliCare has signed a five-year Master Subscription Agreement with Victorian not-for-profit provider mecwacare to roll out its analytics, IoT and integrated nurse call platform across 22 residential aged care facilities supporting about 1,600 re...
InteliCare Halts Trading Ahead of Strategic Partnership Announcement
Mar 10, 2026
InteliCare Holdings Limited has requested and been granted a trading halt on its securities by the ASX, effective 11 March 2026, as it prepares to release an announcement to the market. The halt will remain in place until either the commencement o...
InteliCare Half-Year Loss Widens as Revenue Dips and Balance Sheet Remains Weak
Feb 26, 2026
InteliCare Holdings Limited reported a weaker half-year result for the period ended 31 December 2025, with revenue from ordinary activities slipping 2.3% to $489,707 while its after-tax loss widened 77.1% to $1,367,939 compared with the prior corr...
InteliCare Advances Aged-Care Deployments and Nears CEO Appointment
Jan 29, 2026
InteliCare reported steady operational progress in the December 2025 quarter, advancing commercial discussions with major aged care provider mecwacare toward a broader agreement to deploy its platform across 22 residential facilities and expanding...
InteliCare Posts Quarterly Cash Outflow but Ends December with Stronger Cash Balance
Jan 29, 2026
InteliCare Holdings Limited reported a net operating cash outflow of A$706,000 for the quarter ended 31 December 2025, with customer receipts of A$121,000 outweighed by staff, administration, manufacturing, and marketing expenses. The company offs...
InteliCare Confirms Compliance and Transparency on New Performance Rights Issue
Jan 9, 2026
InteliCare Holdings Limited has notified the market that it has issued performance rights and confirms it remains in full compliance with its financial reporting and continuous disclosure obligations under the Corporations Act. The company states ...
InteliCare Plans Issue of 4.5 Million Performance Rights
Jan 9, 2026
InteliCare Holdings Limited has announced a proposed issue of up to 4.5 million performance rights (ASX code: ICRAP). The issue, structured as a placement or other type of securities issue and scheduled for 9 January 2026, signals the company̵...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.